UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025501
Receipt number R000029350
Scientific Title Exploratory study of adverse events at the unexperienced hospital in the treatment for gastric cancer with peritoneal metastasis with intraperitoneal paclitaxel combined with S-1 plus oxaliplatin
Date of disclosure of the study information 2017/02/28
Last modified on 2024/01/09 18:55:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study of adverse events at the unexperienced hospital in the treatment for gastric cancer with peritoneal metastasis with intraperitoneal paclitaxel combined with S-1 plus oxaliplatin

Acronym

Exploratory study of adverse events in SOX+IP PTX for peritoenal metastasis of gastric cancer

Scientific Title

Exploratory study of adverse events at the unexperienced hospital in the treatment for gastric cancer with peritoneal metastasis with intraperitoneal paclitaxel combined with S-1 plus oxaliplatin

Scientific Title:Acronym

Exploratory study of adverse events in SOX+IP PTX for peritoenal metastasis of gastric cancer

Region

Japan


Condition

Condition

gastric cancer with peritoneal metastasis

Classification by specialty

Gastroenterology Hematology and clinical oncology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety of intraperitoneal paclitaxel combined with S-1 plus oxaliplatin in gastric cancer patients with peritoneal metastasis at the the unexperienced hospital.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

safety

Key secondary outcomes

1-year overall survival
response rate
negative conversion rate on peritoneal cytology


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

PTX is administered intraperitoneally at 40 mg/m2 on days 1 and 8.
S-1 is administered at 80 mg/m2/day for 14 consecutive days, followed by 7 days rest.
Oxaliplatin is administered at 100 mg/m2 on day1.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Histologically proven unresectable or recurrent gastric adenocarcinoma; peritoneal metastasis and/or cancer cells on peritoneal cytology; age more than 20 years; Eastern Cooperative Oncology Group performance status 0-2; adequate bone marrow function (leukocyte count 3,000-12,000/mm3, hemoglobin >8.0 g/dl, platelet count >100,000/mm3); adequate liver function (total serum bilirubin <1.5 mg/dl, serum transaminases <100/UI); adequate renal function (serum creatinine within the upper limit of normal); and an expected survival period of more than 3 months.

Key exclusion criteria

Metastasis to distant organ sites (such as the liver, lungs or bone), other active concomitant malignancies, or other severe medical condition.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hironori
Middle name
Last name Yamaguchi

Organization

Jichi Medical University

Division name

Department of Clinical Oncology

Zip code

329-0498

Address

3311-1 Yakushiji Shimotsukeshi Tochigi

TEL

0285-44-2111

Email

yamaguchih-tky@umin.net


Public contact

Name of contact person

1st name Hironori
Middle name
Last name Hironori

Organization

Jichi Medical University

Division name

Department of Clinical Oncology

Zip code

329-0498

Address

3311-1 Yakushiji Shimotsukeshi Tochigi

TEL

0285-44-2111

Homepage URL


Email

yamaguchih-tky@umin.net


Sponsor or person

Institute

Jichi Medical University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Jichi medical university clinical research support center

Address

3311-1 Yakushiji Shimotsukeshi Tochigi

Tel

0285-58-8933

Email

shien@jichi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

自治医科大学附属病院(栃木県)


Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 05 Month 12 Day

Date of IRB

2017 Year 05 Month 10 Day

Anticipated trial start date

2017 Year 05 Month 29 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 03 Day

Last modified on

2024 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029350


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name